Lexicon Pharmaceuticals to Present at the Piper Jaffray 19th Annual Health Care Conference
November 26 2007 - 4:15PM
PR Newswire (US)
THE WOODLANDS, Texas, Nov. 26 /PRNewswire-FirstCall/ -- Lexicon
Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced that a member
of Lexicon senior management will present at the Piper Jaffray 19th
Annual Health Care Conference at The Pierre Hotel in New York, New
York on Wednesday, November 28, 2007 at 8:30 a.m. Eastern Time. A
live webcast of the presentation may be accessed on Lexicon's
corporate website at http://www.lexpharma.com/. An archived version
of the webcast will be available on the website through December 4,
2007. About Lexicon Lexicon is a biopharmaceutical company focused
on the discovery and development of breakthrough treatments for
human disease. Lexicon currently has clinical programs underway for
such areas of major unmet medical need as irritable bowel syndrome
and cognitive disorders. The company has used its proprietary gene
knockout technology to discover more than 100 promising drug
targets and create an extensive pipeline of clinical and
preclinical programs in the therapeutic areas of diabetes and
obesity, cardiovascular disease, psychiatric and neurological
disorders, cancer, immune system disorders and ophthalmic disease.
To advance the development and commercialization of its programs,
Lexicon is working both independently and through collaborators
including Bristol-Myers Squibb Company, Genentech, Inc. and N.V.
Organon. For additional information about Lexicon and its programs,
please visit http://www.lexpharma.com/. Safe Harbor Statement This
press release contains "forward-looking statements," including
statements relating to Lexicon's growth and future operating
results, discovery and development of products, strategic alliances
and intellectual property, as well as other matters that are not
historical facts or information. All forward-looking statements are
based on management's current assumptions and expectations and
involve risks, uncertainties and other important factors that may
cause Lexicon's actual results to be materially different from any
future results expressed or implied by such forward-looking
statements. Information identifying such important factors is
contained under "Factors Affecting Forward-Looking Statements" and
"Risk Factors" in Lexicon's annual report on Form 10-K for the year
ended December 31, 2006, as filed with the Securities and Exchange
Commission. Lexicon undertakes no obligation to update or revise
any such forward-looking statements, whether as a result of new
information, future events or otherwise. DATASOURCE: Lexicon
Pharmaceuticals, Inc. CONTACT: Bobbie Faulkner, Manager, Investor
Relations of Lexicon Pharmaceuticals, Inc., +1-281-863-3503, Web
site: http://www.lexpharma.com/
Copyright
Lexicon Pharmaceuticals (NASDAQ:LXRX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Lexicon Pharmaceuticals (NASDAQ:LXRX)
Historical Stock Chart
From Jul 2023 to Jul 2024